Recent Findings on DNA-Encoded Monoclonal Antibodies Represent a Major Breakthrough in Medicine A new study published in Nature Medicine shows promising results for DNA-Encoded Monoclonal Antibodies in combating diseases like COVID-19, revealing their effective and durable performance over 72 weeks.

Recent Findings on DNA-Encoded Monoclonal Antibodies Represent a Major Breakthrough in Medicine #USA #INOVIO #Plymouth_Meeting #COVID-19 #DMAbs

INOVIO Unveils Striking Interim Results from Innovative COVID-19 DMAbs Trial INOVIO Pharmaceuticals has released hopeful interim results from its Phase 1 trial assessing DNA-encoded monoclonal antibodies for COVID-19, showcasing sustained antibody levels over 72 weeks.

INOVIO Unveils Striking Interim Results from Innovative COVID-19 DMAbs Trial #USA #INOVIO #Plymouth_Meeting #COVID-19 #DMAbs